- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cells ; 9 (2020), 9. - Art.-Nr. 2103. - eISSN 2073-4409
- Schlagwort
-
Plattenepithelcarcinom
Squamöser Krebs
Antigen
T-Lymphozyt
Impfung
Antikörper
Immuntherapie
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2020
- Urheber
-
von Witzleben, Adrian
Wang, Chuan
Laban, Simon
Savelyeva, Natalia
Ottensmeier, Christian H.
- DOI
-
10.18725/OPARU-43178
- URN
-
urn:nbn:de:bsz:289-oparu-43254-9
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- von Witzleben, Adrian
- Wang, Chuan
- Laban, Simon
- Savelyeva, Natalia
- Ottensmeier, Christian H.
- Universität Ulm
Entstanden
- 2020
Ähnliche Objekte (12)
Mutated tumour antigens as targets of cancer immunotherapy=Mutierte Tumorantigene in der Krebsimmuntherapie
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Characterization of T-cell epitopes for antigen-specific immunotherapy concepts targeting myeloproliferative neoplasms and multiple myeloma
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Comprehensive analysis of tumour sub-volumes for radiomic risk modelling in locally advanced HNSCC
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
Mutated neo-antigens as targets for individualized cancer immunotherapy
The development of antibodies against tumour-associated carbohydrate antigens
Mutated tumour antigens as targets of cancer immunotherapy=Mutierte Tumorantigene in der Krebsimmuntherapie
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Characterization of T-cell epitopes for antigen-specific immunotherapy concepts targeting myeloproliferative neoplasms and multiple myeloma
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Comprehensive analysis of tumour sub-volumes for radiomic risk modelling in locally advanced HNSCC
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
Mutated neo-antigens as targets for individualized cancer immunotherapy
The development of antibodies against tumour-associated carbohydrate antigens
Mutated tumour antigens as targets of cancer immunotherapy=Mutierte Tumorantigene in der Krebsimmuntherapie
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Characterization of T-cell epitopes for antigen-specific immunotherapy concepts targeting myeloproliferative neoplasms and multiple myeloma
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemoand immunotherapy
Comprehensive analysis of tumour sub-volumes for radiomic risk modelling in locally advanced HNSCC
Immune checkpoint expression on immune cells of HNSCC patients and modulation by chemo- and immunotherapy
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
A cancer immunotherapy approach targeting mutant isocitrate dehydrogenase 1
Cellular mechanisms of antigen-specific immunotherapy of autoimmune disease
Mutated neo-antigens as targets for individualized cancer immunotherapy